Bill would classify animal sedative xylazine as controlled substance
Placed on the calendarS. 545Latest action
Sponsor: Catherine Cortez Masto · Senator · NV
AIDecoded by AI · checked against the recordRead the official text
Official title: Combating Illicit Xylazine Act
119th Congress
Topics: Crime & justice
Introduced:
Read the official bill on Congress.govIn plain words
The plain-language version comes first. The official text is always the reference.
S 545 would make xylazine, a sedative found mixed into street fentanyl, a federally controlled Schedule III drug.
35-second read · 4 questions answered below
What does this do?
The bill classifies xylazine as a Schedule III controlled substance, creating federal criminal penalties for illegal manufacturing, distribution, or possession outside veterinary or medical use. It also delays new labeling and registration rules and requires several government reports on xylazine misuse and trafficking.
Who does it affect?
Veterinarians, pharmacies, animal shelters, wildlife agencies, pet owners, and drug manufacturers are affected, as are law enforcement and people involved in illegal drug distribution.
Why does it matter?
The classification adds federal criminal penalties for illicit xylazine use while preserving normal veterinary and animal-care access, and directs agencies to study and respond to its role in drug trafficking and overdoses.
AI-drafted summary. Check it against the official text before you act on it.
Based on the “Reported to Senate” text of Apr 15, 2026.
Read the official bill on Congress.govMake the call
Where does it stand?
- IntroducedFeb 12, 2025
- Senate committee
- Senate voteYou are here · Apr 15, 2026
- House
- The president's desk
Right now: it was placed on the , and the official record shows no floor action on it since. If the House changes it, it goes back to the Senate before reaching the president.
Latest action: — Placed on Senate Legislative Calendar under General Orders. Calendar No. 372.